Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04861636 · ClinicalTrials.gov registry record · NA

Teen Weight Control

A NA study of Weight Loss and Adolescent Obesity, sponsored by The Miriam Hospital.

Active
Registry status
NA
Development phase
172
Enrollment target
3
Study locations

NCT04861636: Active NA study of Weight Loss and Adolescent Obesity, sponsored by The Miriam Hospital.

NCT04861636 is a NA study of Weight Loss and Adolescent Obesity that is active but no longer recruiting, run by The Miriam Hospital. The registered enrollment target is 172 participants, below the 1,500-participant average among 116 other Weight Loss trials with a reported enrollment target (89% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04861636, a NA study of Weight Loss and Adolescent Obesity, is active but no longer recruiting, sponsored by The Miriam Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
172 participants
Enrollment target
3
Study locations

Study Summary

The prevalence of obesity in adolescents is remarkably high, with 38.7% of youth 12-15 years of age and 41.5% of 16-19 year olds meeting criteria for overweight or obesity. Behavioral weight control interventions for adolescents have had limited impact on this field and there is considerably more that needs to be done. Notably, adolescents who have difficulty managing their feelings have been found to consume higher caloric foods and report greater amounts of sedentary time. Poor emotion management among adolescents has also been associated with more rapid weight gain and higher BMI. Data from adolescents with overweight/obesity attending our outpatient weight management program (N=124) indicate that 82% of these youth report emotion regulation scores that are comparable to youth with significant mental health problems. Despite documented relationships between adolescent weight control and emotion regulation, no proven adolescent weight management programs targeting emotion regulation exist. To fill this gap, our laboratory developed and piloted an adolescent weight control intervention (HealthTRAC) that combines two previously tested effective interventions, one targeting emotion regulation skill building, the other focused on behavioral weight control. Findings from our small pilot trial are promising and indicate that the newly created HealthTRAC intervention is acceptable to parents and teens, easy to deliver, and leads to modest weight loss and improved emotion management skills compared to a standard behavioral weight control (SBWC) program. These data suggest that emotion regulation is related to weight management and may assist adolescents with overweight/obesity who are seeking to lose weight. The current multi-site study builds on this previous work and will examine the impact of the developed HealthTRAC intervention on improving emotion regulation skills and reducing adolescent BMI in a larger sample with longer term follow-up (18 months after starting th

Primary Outcome

Weight (kilograms) and height (meters\^2) will be used to calculate body mass index (BMI; kg/m\^2)

Interventions

  • BEHAVIORAL HealthTRAC
  • BEHAVIORAL SBWC

Study Locations (3)

Oregon

  • University of Oregon - Eugene
  • Oregon Health & Science University - Portland

Rhode Island

  • The Miriam Hospital - Providence

Trial Details

FieldValue
Enrollment Target 172 participants
Start Date 2021-05-01
Est. Completion 2026-01-31
Phase NA
The Miriam Hospital

136 total trials

What the registry record for NCT04861636 still lists

NCT04861636 is an interventional study that assigns participants to a tested intervention. The registered 172 participants enrollment target is mid-sized for trials with a published cap, below the 1,500-participant average among 116 other Weight Loss trials with a reported enrollment target (89% lower).

The record links to 2 conditions, with Weight Loss appearing as the primary indexed condition, and to 2 interventions - of which HealthTRAC is the first listed.

NCT04861636 reports a single indexed study location in Oregon, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT04861636 about?

NCT04861636 is a clinical study titled "Teen Weight Control". The prevalence of obesity in adolescents is remarkably high, with 38.7% of youth 12-15 years of age and 41.5% of 16-19 year olds meeting criteria for overweight or obesity. Behavioral weight control interventions for adolescents have had limited impact on this field and there is considerably more th...

What is the current status of trial NCT04861636?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 172 participants. The study started on 2021-05-01. Estimated completion is 2026-01-31.

What conditions does trial NCT04861636 study?

This clinical trial studies the following conditions: Weight Loss, Adolescent Obesity.

What interventions are being tested in trial NCT04861636?

The interventions under investigation include: HealthTRAC (BEHAVIORAL), SBWC (BEHAVIORAL).

Who is sponsoring clinical trial NCT04861636?

This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04861636 being conducted?

This trial has 3 study locations across Oregon, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Weight Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04861636's enrollment target sits among peer trials

172 32nd of 116 higher than 85 of 116 other Weight Loss trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Weight Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04801797 · 172 participants · Phase 2

    Venetoclax + Azacitidine vs. Induction Chemotherapy in AML

  • NCT04867317 · 172 participants · Phase 3

    Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)

  • NCT05357040 · 172 participants · Phase 2

    Antidepressant Effects of Nitrous Oxide

  • NCT05587517 · 172 participants · Phase 2

    A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04861636, the US trial registry maintained by the National Library of Medicine. NCT04861636 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.